Stock FCM FRIULCHEM S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Friulchem S.p.A.

Equities

FCM

IT0005378457

Pharmaceuticals

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-04-26 am EDT 		5-day change 1st Jan Change
0.96 EUR 0.00% Intraday chart for Friulchem S.p.A. +2.13% -4.00%
Mar. 22 Friulchem returns to profit in 2023; increases financial debt AN
Mar. 22 Friulchem S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2021 2022 2023 2024 2025
Capitalization 1 12.72 10 6.42 5.76 5.76 -
Enterprise Value (EV) 1 11.57 13.07 11.82 14.62 18.46 18.16
P/E ratio - 125 x - -24 x -96 x 12 x
Yield - - - - - -
Capitalization / Revenue 0.8 x 0.44 x 0.19 x 0.23 x 0.19 x 0.17 x
EV / Revenue 0.72 x 0.57 x 0.34 x 0.55 x 0.61 x 0.52 x
EV / EBITDA 6.9 x 8.27 x 7.39 x 9.74 x 10.3 x 6.98 x
EV / FCF 10.8 x - - -3.48 x -4.5 x 60.5 x
FCF Yield 9.24% - - -28.7% -22.2% 1.65%
Price to Book - 0.71 x - 0.73 x 0.74 x 0.7 x
Nbr of stocks (in thousands) 8,000 8,000 6,000 6,000 6,000 -
Reference price 2 1.590 1.250 1.070 0.9600 0.9600 0.9600
Announcement Date 3/24/20 3/23/22 3/23/23 3/22/24 - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2021 2022 2023 2024 2025
Net sales 1 15.99 22.88 34.26 26.66 30.5 34.7
EBITDA 1 1.677 1.581 1.6 1.5 1.8 2.6
EBIT 1 0.683 0.689 0.512 0.639 0.7 1.6
Operating Margin 4.27% 3.01% 1.49% 2.4% 2.3% 4.61%
Earnings before Tax (EBT) 1 - 0.269 -0.057 -0.276 -0.1 0.9
Net income 1 - 0.084 0.033 -0.299 -0.1 0.6
Net margin - 0.37% 0.1% -1.12% -0.33% 1.73%
EPS 2 - 0.0100 - -0.0400 -0.0100 0.0800
Free Cash Flow 1 1.069 - - -4.5 -4.1 0.3
FCF margin 6.69% - - -14.9% -13.44% 0.86%
FCF Conversion (EBITDA) 63.74% - - - - 11.54%
FCF Conversion (Net income) - - - - - 50%
Dividend per Share - - - - - -
Announcement Date 3/24/20 3/23/22 3/23/23 3/22/24 - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2021 2022 2023 2024 2025
Net Debt 1 - 3.08 5.4 8.62 12.7 12.4
Net Cash position 1 1.15 - - - - -
Leverage (Debt/EBITDA) - 1.945 x 3.375 x 5.743 x 7.056 x 4.769 x
Free Cash Flow 1 1.07 - - -4.5 -4.1 0.3
ROE (net income / shareholders' equity) - 0.79% 0.31% - - 5.8%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - 1.760 - 1.310 1.290 1.370
Cash Flow per Share 2 - - - -0.1200 - -
Capex 0.21 - - - - -
Capex / Sales 1.3% - - - - -
Announcement Date 3/24/20 3/23/22 3/23/23 3/22/24 - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Friulchem S.p.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.96 EUR
Average target price
1.2 EUR
Spread / Average Target
+25.00%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
FRIULCHEM S.P.A. Stock Friulchem S.p.A.
-4.00% 6.15M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. FCM Stock
  4. Financials Friulchem S.p.A.